Related Experiment Video

Updated: Jul 8, 2025

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
08:50

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development

Published on: June 24, 2020

3.8K

Maternal penicillin allergy and infant outcomes: Results from a large administrative cohort

Laura A Wang1, Rebecca J Baer2, Jennifer A Namazy3

  • 1Department of Pediatrics, Division of Allergy and Immunology, University of Colorado, Aurora, Colo.

The Journal of Allergy and Clinical Immunology. in Practice
|December 13, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

10.4K
Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring
09:09

Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring

Published on: August 17, 2022

1.7K

Related Experiment Videos

Last Updated: Jul 8, 2025

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
08:50

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development

Published on: June 24, 2020

3.8K
Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

10.4K
Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring
09:09

Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring

Published on: August 17, 2022

1.7K

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Development of Immunocompetence01:22

Development of Immunocompetence

312
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
312

Articles linked to this work by shared authors, journal, and citation graph.

Clinical Practice Outcomes With Lecanemab for Alzheimer Disease.

Neurology open access·2026

Racial differences in cardiovascular events and adverse pregnancy outcomes among pregnant individuals with SLE.

Lupus science & medicine·2026

Nailfold Capillary Morphology as a Potential Biomarker of Cardiovascular or Metabolic Risk in Children Aged 3-17 Years Prenatally Exposed to Alcohol.

Alcohol, clinical & experimental research·2026

Challenges and Insights from the Mepolizumab Pregnancy Exposure Study.

Drug safety·2026

Intellectual and developmental disability diagnoses in California delivery records and adverse maternal outcomes.

Pregnancy (Hoboken, N.J.)·2026

Spoken language and risk of nulliparous, term, singleton, vertex cesarean births in California, 2016 to 2021.

American journal of obstetrics & gynecology MFM·2026

Sustained low disease activity during long-term mepolizumab treatment in FIP1L1::PDGFRA-negative hypereosinophilic syndrome: a multicenter real-world study.

The journal of allergy and clinical immunology. In practice·2026

Supporting asthma guideline-based management by integrating patient navigators.

The journal of allergy and clinical immunology. In practice·2026

Risk of Respiratory Tract Infections with Asthma Biologics.

The journal of allergy and clinical immunology. In practice·2026

Proposed Strategies to Increase the Likelihood of Achieving Remission in CRSwNP by EUFOREA.

The journal of allergy and clinical immunology. In practice·2026

The Impact of Dupilumab Treatment on the Management of Co-Morbid Food Allergy.

The journal of allergy and clinical immunology. In practice·2026

Association Between anti-PD-1/PD-L1 Immune Checkpoint Inhibitors and Type 2 Airway Inflammation in Patients with Lung Cancer: the IMMUNEO Retrospective Case Series.

The journal of allergy and clinical immunology. In practice·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us